TD Cowen Maintains Hold on Legend Biotech, Raises Price Target to $29

Legend Biotech

Legend Biotech

LEGN

0.00

TD Cowen analyst Yaron Werber maintains Legend Biotech (NASDAQ: LEGN) with a Hold and raises the price target from $21 to $29.